Trial intelligence / Profile preview

Ibuprofen + acetaminophen for primary dysmenorrhoea

ISRCTN42521357Phase 3Completed

Sponsor
Reckitt
Start
Jan 2009
Modality
Small Molecules
01

Overview

Phase 3, randomised trial in primary dysmenorrhea (PD) comparing Ibuprofen + acetaminophen fixed-dose combination with Placebo (2 arms). Primary endpoint: Total pain relief over 6 hours post-dose. Started Jan 2009; status: completed.

02

Drugs

ibuprofenacetaminophen
03

Conditions

primary dysmenorrhea (PD)

Beyond the preview

Go deeper on ISRCTN42521357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN42521357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call